The role of magnesium in colorectal cancer: mini-review
- 1Doctoral Program in Chemical-Biological Research, Faculty of Bioanalysis, Veracruzana University, Veracruz, Ver., Mexico
Abstract
Magnesium (Mg2+) is a divalent cation that functions as a cofactor for numerous enzymes and plays a critical role in essential cellular processes, including proliferation, migration, and apoptosis. Over the past decade, Mg2+ has gained increasing attention as a potential protective factor against colorectal cancer (CRC), as higher dietary Mg2+ intake has been associated with a reduced risk of disease development. Emerging evidence also suggests that Mg2+ supplementation may modulate the gut microbiome and enhance vitamin D synthesis, which could further contribute to CRC prevention. In addition, some in vitro studies suggest that Mg2+ may reduce the survival of human colon cancer cells, supporting a potential antitumor role. Conversely, dysregulation of Mg2+ channels and transporters has been reported in CRC and has been associated with chemoresistance, metastasis, tumor progression, and poorer clinical prognosis. Clinically, hypomagnesemia is frequently observed in CRC patients, particularly in those receiving anti-EGFR therapies, and has been proposed as a potential, although still debated, biomarker of treatment response and prognosis. This mini-review summarizes current knowledge regarding Mg2+ homeostasis in the large intestine and discusses the potential implications of Mg2+ transporters and channels in CRC development, progression, and clinical outcomes.
Related
- GAN-enhanced digital twins for biomarker-guided cancer immunotherapy and adoptive cell therapy: a mini review
- Neoadjuvant systemic therapy and the evolution of axillary management in breast cancer: a mini review and future directions
- Prognostic value of the neutrophil-to-lymphocyte ratio in patients with colorectal cancer undergoing chemotherapy: a systematic review and meta-analysis
- Immune remodeling in inflammatory bowel disease-associated colorectal cancer: Mechanisms and immunotherapeutic implications (Review)
- Predictive value of multimodal models combining CT body composition and clinical variables for short-term postoperative complications in colorectal cancer: a systematic review and meta-analysis.
BibTeX
@article{angeles2026role,
title = {{The role of magnesium in colorectal cancer: mini-review}},
author = {Vázquez-Prieto María de los Angeles and Sumoza-Toledo Adriana},
journal = {Oncologie},
year = {2026},
month = sep,
doi = {10.1515/oncologie-2026-0058},
url = {https://doi.org/10.1515/oncologie-2026-0058},
note = {CC BY},
}
RIS
TY - JOUR
TI - The role of magnesium in colorectal cancer: mini-review
AU - Vázquez-Prieto María de los Angeles
AU - Sumoza-Toledo Adriana
PY - 2026
DA - 2026/09/01
JO - Oncologie
DO - 10.1515/oncologie-2026-0058
UR - https://doi.org/10.1515/oncologie-2026-0058
AB - Magnesium (Mg2+) is a divalent cation that functions as a cofactor for numerous enzymes and plays a critical role in essential cellular processes, including proliferation, migration, and apoptosis. Over the past decade, Mg2+ has gained increasing attention as a potential protective factor against colorectal cancer (CRC), as higher dietary Mg2+ intake has been associated with a reduced risk of disease development. Emerging evidence also suggests that Mg2+ supplementation may modulate the gut microbiome and enhance vitamin D synthesis, which could further contribute to CRC prevention. In addition, some in vitro studies suggest that Mg2+ may reduce the survival of human colon cancer cells, supporting a potential antitumor role. Conversely, dysregulation of Mg2+ channels and transporters has been reported in CRC and has been associated with chemoresistance, metastasis, tumor progression, and poorer clinical prognosis. Clinically, hypomagnesemia is frequently observed in CRC patients, particularly in those receiving anti-EGFR therapies, and has been proposed as a potential, although still debated, biomarker of treatment response and prognosis. This mini-review summarizes current knowledge regarding Mg2+ homeostasis in the large intestine and discusses the potential implications of Mg2+ transporters and channels in CRC development, progression, and clinical outcomes.
SN - 1765-2839
SN - 1292-3818
ER -